{"id":"NCT01228071","sponsor":"Endo Pharmaceuticals","briefTitle":"Time to Eugonadal Range, Time to Steady State and Drying Time","officialTitle":"Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2011-05","completion":"2011-05","firstPosted":"2010-10-25","resultsPosted":"2013-07-22","lastUpdate":"2017-10-05"},"enrollment":34,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Male Hypogonadism"],"interventions":[{"type":"DRUG","name":"testosterone gel 2%","otherNames":["EN3350"]}],"arms":[{"label":"40 mg daily dose of testosterone gel 2%","type":"EXPERIMENTAL"}],"summary":"This is a multicenter, open-label, single arm trial to evaluate the time to eugonadal testosterone range after initial testosterone gel 2% application, time to steady state after after initiation of testosterone gel 2%, and drying time after application of testosterone gel 2%.","primaryOutcome":{"measure":"Time to Target Eugonadal Range","timeFrame":"24 hours","effectByArm":[{"arm":"40 mg Daily Dose of Testosterone Gel 2%","deltaMin":2.85,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["Application site dryness","Application site rash","Diarrhoea","Headache","Productive cough"]}}